Ledger.Open graph →
SEC Form D · filed January 5, 2017

Centrexion Therapeutics Corp

Offering
$16.6M
Sold
$16.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Isaac Blech · Baltimore, MDDirectorRobert Van Doorn · Vancouver, British Columbia, CanadaDirectorGregg L. Beloff · Baltimore, MDExecJoshua Tolman · Chicago, ILExec · DirectorJames N. Campbell · Baltimore, MDExec · DirectorBrian K. Niles · Boca Raton, FLDirectorChuck Templeton · Chicago, ILExecDonald L. Dillingham · Oklahoma City, OKExecArnold L. Oronsky · Baltimore, MDDirectorDennis S. Swanson · Bassett, NEDirectorDonald S. Allen · North Platte, NEExecDavid D. Gale · Bassett, NEExec · DirectorEileen Murphy · Chicago, ILDirectorShengda L. Zan · Baltimore, MDDirectorJerry R. Masters · Parker, COExec · DirectorAntonio Canton · Vancouver, British Columbia, CanadaExecTheodore A. Klug · Bassett, NEExecShana M. Ostrovitz · Boca Raton, FLDirectorKerrie L. Brady · Baltimore, MDExecWarren R. Arganbright · Valentine, NEDirectorJeffrey B. Kindler · Baltimore, MDExecSol Barer · Baltimore, MDDirectorAbby Ross · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗